Close

Rating History for AbCellera Biologics (ABCL) by Benchmark

Date Analyst Type Rating
(Past)
PT
(Past)
Start $
(End $)
% Chg. Details
2/22/2024 Robert Wasserman Upgrade Buy
(Hold)
N/A
(N/A)
4.81
(4.87)
1.25% Details